HIV/AIDS Press Release

The University of California today (June 3) announced the distribution of $2 million in seed funding for important research across the state aimed at mitigating the impact of COVID-19, particularly among those at greater risk for infection and adverse outcomes. UC awarded the funds to support rapid-response, high-impact research in vaccines, therapeutics, clinical management, epidemiology and other COVID-19 related areas. In addition to UC campuses, other institutions of higher education as well as private and nonprofit groups in California received awards.

HERTFORDSHIRE, England and PITTSBURGH , May 29, 2020 / / -- Mylan N.V.  (NASDAQ: MYL) today announced that the U.S. Patent and Trademark Appeal Board (PTAB) has ruled in favor of Mylan in inter partes review (IPR) proceedings finding all challenged claims of Sanofi's Lantus® SoloSTAR® device patents, U.S. Patent Nos.

Dr. Gordon Douglas, a Class of 1955 alumnus, has decades of experience looking at vaccines from all sides: as a practicing physician, as a professor in medical schools, as a medical investigator, as the president of Merck?s vaccine division , in his work with start-up companies developing new drugs and vaccines, and in his efforts to distribute tuberculosis vaccines to developing nations.

Independent Data Monitoring Committee (DMC) to Review and Evaluate Patient Safety and Efficacy Data for Pivotal Phase 3 Trial of Galinpepimut-S in Patients with Acute Myeloid Leukemia in Second Remission Moshe Talpaz, M.D., Associate Director of Translational Research and Associate Chief of the Division of Hematology/Oncology at the University of Michigan Comprehensive Cancer Center to serve as DMC Chair Thomas Fleming, Ph.

Dear Speaker Pelosi, Minority Leader McCarthy, Majority Leader McConnell, and Minority Leader Schumer:

Even after successful antiretroviral therapy, HIV can hide dormant in a tiny number of immune system cells for decades and re-emerge to threaten the life of its host. Now Yale University researchers have discovered a molecular explanation for how the virus accomplishes this insidious trick, they report May 13 in the journal Science Translational Medicine.

HERTFORDSHIRE, England and PITTSBURGH, May 12, 2020 / / -- Mylan N.V. (NASDAQ: MYL) today announced, as part of its ongoing efforts to support patients and public health needs during the COVID-19 pandemic, a global collaboration with Gilead Sciences to expand access to the investigational antiviral remdesivir for the potential treatment of COVID-19. 

PETA Urges Congressional Leaders to Recognize 'Research Modernization Deal' As Animal Experiments Fail to Provide Treatments, Vaccines.

Scanning electron microscope image of SARS-CoV-2, isolated from a patient, emerging from the surface of cells cultured in the lab. Image captured and color-enhanced by National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases.

In a Science perspective, experts urge multi-pronged, coordinated approach to successfully develop COVID-19 vaccines.

Bainbridge Island Regional Medical Center (shown here) is one of eight locations where Virginia Mason provides outpatient services. There others are the main Virginia Mason campus on First Hill in Seattle; Bellevue; Edmonds; Federal Way; Issaquah; Kirkland; Lynnwood; and University Village near the University of Washington campus.

SEATTLE – (May 7, 2020) – Virginia Mason has joined 14 other medical institutions and cancer research centers across the nation in activating Precision Promise, the Pancreatic Cancer Action Network’s (PanCAN) innovative adaptive clinical trial designed to accelerate exploration and approval of new treatment options.